M&A - BIOCRYST PHARMACEUTICALS INC

Form Type: 8-K

Filing Date: 2025-06-27

Corporate Action: Acquisition

Type: New

Accession Number: 000117184325004186

Filing Summary: On June 27, 2025, BioCryst Pharmaceuticals, Inc. announced the execution of a Stock Purchase Agreement for the acquisition of all equity interests in BioCryst Ireland Limited and its subsidiaries. Neopharmed Gentili S.p.A., an Italian corporation, is the purchaser. The agreement signals a strategic move by BioCryst to consolidate its business under the control of Neopharmed, which may influence future operations and financial strategies. A press release detailing the execution was attached as Exhibit 99.1 to the Form 8-K.